产品详情
Targets
Target | Value | |
---|---|---|
Bcl-w | IC50: 0.02μM | |
Bcl-B | IC50: 0.66μM | |
Mcl-1 | IC50: 0.79μM | |
Bfl-1 | IC50: 1.06μM | |
Bcl-2 | IC50: 1.21μM | |
Bcl-xL | IC50: 1.47μM | |
Caspase | EC50 | <1.64μM |
In vitro (25°C) | DMSO | 97 mg/mL (154.27 mM) | |
Water | Insoluble | ||
Ethanol | 97 mg/mL (154.27 mM) | ||
In vivo | 2% DMSO+40% PEG 300+2% Tween 80+ddH2O | 3 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 15.9 mL | 79.52 mL | 159.05 mL |
0.5 mM | 3.18 mL | 15.9 mL | 31.81 mL |
1 mM | 1.59 mL | 7.95 mL | 15.9 mL |
5 mM | 0.32 mL | 1.59 mL | 3.18 mL |
*The above data is based on the productmolecular weight 628.75. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A11988 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 628.75 |
Formula | C38H44O8 |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 2752-65-0 |
SMILES | CC(=CCC[C@@]1(C=CC2=C(O1)C(=C3C(=C2O)C(=O)C4=C[C@@H]5C[C@@H]6[C@@]4(O3)[C@](C5=O)(OC6(C)C)C/C=C(/C)\C(=O)O)CC=C(C)C)C)C |
产品标签
Product Questions
Product Questions
AT101 acetic acid
AT101 acetic acid对映体AT101与Bcl-2,Bcl-xL和Mcl-1结合,Ki分别为0.32μM,0.48μM和0.18μM;不抑制BIR3域和BID。
ABT-263 (Navitoclax)
ABT-263 (Navitoclax)是一种有效的Bcl-2家族抑制剂 (Bcl-2,Bcl-xL和Bcl-w的Ki
LY573636 (Tasisulam)
LY573636 (Tasisulam)是一种有效的抗肿瘤剂,在体外和体内引起多种人实体瘤的生长停滞和凋亡。LY573636诱导的…
Bcl-2 Inhibitor
Bcl-2 Inhibitor包含两种互变异构体的混合物。一种有效的,细胞可渗透的Bcl-2抑制剂与Bak BH3肽竞争体外结合Bc…
Cyclophosphamide monohydrate
Cyclophosphamide monohydrate是一种烷基化的细胞毒剂,经实验证明可以使DNA交联,从而引起链断裂和诱导突变。